CALLEGARI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 3.832
AS - Asia 1.788
EU - Europa 1.248
SA - Sud America 242
AF - Africa 43
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.158
Nazione #
US - Stati Uniti d'America 3.743
SG - Singapore 693
CN - Cina 450
IT - Italia 275
DE - Germania 235
VN - Vietnam 211
BR - Brasile 182
PL - Polonia 165
HK - Hong Kong 136
GB - Regno Unito 113
UA - Ucraina 100
FI - Finlandia 98
TR - Turchia 64
FR - Francia 50
ID - Indonesia 44
CA - Canada 42
RU - Federazione Russa 38
IN - India 37
JP - Giappone 35
MX - Messico 34
SE - Svezia 32
BD - Bangladesh 31
AR - Argentina 24
RO - Romania 22
NL - Olanda 20
ES - Italia 19
CZ - Repubblica Ceca 16
ZA - Sudafrica 14
IQ - Iraq 13
AT - Austria 12
PK - Pakistan 11
LT - Lituania 9
UZ - Uzbekistan 9
VE - Venezuela 9
BE - Belgio 8
CO - Colombia 8
GR - Grecia 8
OM - Oman 7
IE - Irlanda 6
IR - Iran 6
KE - Kenya 6
EC - Ecuador 5
EG - Egitto 5
IL - Israele 5
SA - Arabia Saudita 5
BO - Bolivia 4
CH - Svizzera 4
HU - Ungheria 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
TW - Taiwan 4
AU - Australia 3
CL - Cile 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KR - Corea 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HR - Croazia 2
LV - Lettonia 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.158
Città #
Ashburn 503
Fairfield 456
Singapore 430
San Jose 292
Woodbridge 260
Houston 216
Warsaw 164
Seattle 163
Beijing 153
Wilmington 149
Chandler 144
Munich 141
Ann Arbor 139
Cambridge 135
Hong Kong 131
Santa Clara 126
Jacksonville 110
New York 79
Ferrara 77
Ho Chi Minh City 67
Los Angeles 63
Helsinki 53
Milan 45
Hanoi 41
Nanjing 41
Dallas 39
Izmir 39
Jakarta 37
Shanghai 36
San Diego 35
Tokyo 35
Princeton 33
Council Bluffs 32
Lauterbourg 31
London 29
São Paulo 23
Bologna 21
Nanchang 20
Boardman 18
Jinan 18
Turku 18
Chicago 17
Orem 17
Timisoara 17
Mexico City 16
Montreal 15
Turin 15
Atlanta 13
Brno 13
Rome 12
Nuremberg 11
Addison 10
Boston 10
Buffalo 10
Dearborn 10
Manchester 10
Moscow 10
San Francisco 10
Shenyang 10
The Dalles 10
Brooklyn 9
Da Nang 9
Denver 9
Frankfurt am Main 9
Hangzhou 9
Hefei 9
Washington 9
Belo Horizonte 8
Dong Ket 8
Falls Church 8
Haiphong 8
Johannesburg 8
Mountain View 8
Phoenix 8
Stockholm 8
Toronto 8
Tampa 7
Tashkent 7
Vancouver 7
Brussels 6
Changsha 6
Dublin 6
Düsseldorf 6
Hebei 6
Querétaro 6
Ankara 5
Auburn Hills 5
Berkeley 5
Chennai 5
Des Moines 5
Guangzhou 5
Hyderabad 5
Jiaxing 5
Kunming 5
Leeds 5
Ningbo 5
Norwalk 5
Paris 5
Poplar 5
Salt Lake City 5
Totale 5.145
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 402
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 298
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 295
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 283
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 262
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 252
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 247
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 235
MicroRNA involvement in hepatocellular carcinoma 233
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 233
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 220
Animal Models of Hepatocellular Carcinoma Prevention 214
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 212
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 208
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 207
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 206
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 204
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 200
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 194
MicroRNA response to environmental mutagens in liver 193
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 191
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 185
Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients 182
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 179
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 172
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 170
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 162
MicroRNAs in Animal Models of HCC 157
Novel Virus Identification through Metagenomics: A Systematic Review 138
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 129
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 124
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 110
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 108
null 107
null 103
null 89
null 63
Role of microRNAs in hepatocellular carcinoma: a clinical perspective 59
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 22
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 12
Totale 7.260
Categoria #
all - tutte 28.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021251 0 0 0 0 0 0 0 0 0 145 54 52
2021/2022399 13 38 52 18 10 29 22 22 17 25 40 113
2022/2023344 32 19 19 46 47 42 40 25 41 0 21 12
2023/2024305 15 35 15 6 21 77 11 39 6 6 7 67
2024/20251.183 30 25 77 35 121 143 61 63 235 114 139 140
2025/20262.570 301 67 189 290 414 176 420 167 275 271 0 0
Totale 7.260